Illumina CEO Francis deSouza disclosed that his company has developed a new sequencing-by-synthesis (SBS) chemistry—codenamed “Chemistry X” pending a permanent name. He said Chemistry X will deliver 2x faster cycle times, as well as 2x longer reads, and 3x greater accuracy than the company’s current SBS chemistry. Additional details of Chemistry X are expected to emerge this fall, when Illumina holds its annual customer/investor day . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

The post X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results appeared first on GEN – Genetic Engineering and Biotechnology News.

Source